Covered recipient · General Payments record
WILLIAM C PIERCE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$7,779.07
- Reported across 362 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,171.17 | 54 |
| Education | $254.90 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $239.43 | 16 |
| AVEO Pharmaceuticals, Inc. | $184.97 | 6 |
| Merck Sharp & Dohme Corporation | $121.97 | 4 |
| E.R. Squibb & Sons, L.L.C. | $120.48 | 4 |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 |
| Janssen Biotech, Inc. | $96.18 | 3 |
| Acerta Pharma LLC | $80.80 | 3 |
| Genentech USA, Inc. | $37.29 | 2 |
| Astellas Pharma US Inc | $35.00 | 1 |
| Acrotech Biopharma Inc. | $34.23 | 2 |
| GENZYME CORPORATION | $32.38 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.89 | 1 |
| ABBVIE INC. | $31.83 | 1 |
| Exelixis Inc. | $31.70 | 1 |
| BeiGene USA, Inc. | $26.28 | 1 |
| Mirati Therapeutics, Inc. | $25.58 | 1 |
| Spectrum Pharmaceuticals Inc. | $23.80 | 1 |
| Tempus AI, Inc | $23.77 | 1 |
| GlaxoSmithKline, LLC. | $22.26 | 1 |
| Blueprint Medicines Corporation | $22.12 | 1 |
| Kyowa Kirin, Inc. | $21.39 | 1 |
| Incyte Corporation | $19.59 | 1 |
| Gilead Sciences, Inc. | $19.40 | 1 |
| Ipsen Biopharmaceuticals, Inc | $18.17 | 1 |
| PharmaEssentia USA Corporation | $18.13 | 1 |
| Organon LLC | $7.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (59)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.